What Steris's latest 10-Q says: 8 signals
Steris filed its latest 10-Q with the SEC on Aug 7, 2026. It discusses acquisition completed, capex increase and inflation impact.
Public (STE)Medical Equipment Manufacturing10,000+ employeessteris.comLinkedIn
- Filed
- Aug 7, 2026
- Filings
- 2
- Signals
- 20
10-Q · latest 10
What Steris's 10-Q filings say
- SEC EDGAR
10-Q
Filed · 8 signals
STERIS flags risks with new NC Center of Excellence and facility consolidation plan
The company is executing a major facility consolidation and building a new Center of Excellence in North Carolina.
STERIS authorizes new $1B share repurchase program, with $900M remaining.
The board's authorization of a new $1 billion share buyback program, with $100 million executed in the quarter, signals significant financial strength and available capital.
$1B
New share repurchase program authorization
STERIS warns inflation and pricing pressure could lead to "erosion of profit margins"
The company is facing significant cost pressures from inflation, which threatens to erode profit margins.
STERIS spent $16M on acquisitions in Q1 FY2027, continuing its M&A strategy.
STERIS spent $16.0 million on acquiring businesses during the quarter, continuing its growth-by-acquisition strategy.
$16M
Acquisition of businesses, net of cash acquired
STERIS hedging 0.5M pounds of nickel to combat volatile raw material costs.
The company is actively using commodity swaps to protect its margins from rising production costs, indicating that input cost inflation is a significant operational concern.
Ongoing Ethylene Oxide (EO) litigation threatens production, marketing, and creates uncovered costs.
STERIS identifies the pending EO litigation as a key risk that could disrupt operations, delay product introductions, and negatively impact financial performance, indicating a need for risk management, compliance, and legal support solutions.
- SEC EDGAR
10-Q
Filed · 12 signals
STERIS divesting its Dental segment, creating need for system and data separation projects.
STERIS has classified its Dental segment as a discontinued operation held for sale, indicating an imminent divestiture.
STERIS confirms ongoing divestiture and restructuring, citing risks in realizing benefits.
The company is actively pursuing divestitures and restructuring but acknowledges the risk that anticipated cost savings and synergies may not be realized.
The company explicitly identifies the risk of failing to successfully integrate acquired businesses, which could lead to higher-than-expected costs and operational difficulties.
STERIS is involved in specific, named litigation concerning ethylene oxide, which poses a risk of uncovered costs and disruption to production, supply, and marketing.
Showing 10 of 20 filing signals. The Signal API returns all of them.
Get them with one API callEarnings calls
Steris earnings headlines
From earnings call transcripts (Signal API type earnings-transcripts).
| Call date | What the company said |
|---|---|
| Long-tenured CFO retiring, successor promoted from within after 20 years.After 17 years, CFO Mike Tokich is retiring and transitioning the role to Karen, a 20-year company veteran prepared for the position. This major leadership change creates a prime opportunity for vendors to engage with new financial leadership, who may be open to reviewing existing systems, processes, and vendor relationships. | |
| Maintaining $375M capital expenditure budget for fiscal year 2026.The company confirmed its full-year CapEx plan of $375 million, with $94 million already spent in Q1. This substantial, committed investment signals ongoing projects and budget availability for infrastructure, new equipment, and related services across its segments. | |
| Healthcare capital orders grew 14% with backlog over $400M, indicating scaling needs.The Healthcare segment saw a 14% increase in underlying capital equipment orders and ended the quarter with a backlog just over $400 million. This strong and sustained demand creates pressure to efficiently manage production, supply chain, and installation, opening opportunities for vendors that can improve operational throughput and project management. | |
| Projecting significant cash build-up for future strategic deployment.The CFO anticipates the company's cash position will continue to grow significantly in the near term, driven by strong performance and a lack of prepayable debt. This growing 'war chest' is being accumulated for future strategic use, likely M&A or other large investments. | |
| Proactively managing new ethylene oxide (EO) NESHAP compliance ahead of competitors.Unlike competitors who sought a 2-year regulatory extension, STERIS is confident in meeting new NESHAP compliance standards for its EO facilities without delay. This focus on advanced engineering and compliance creates opportunities for vendors specializing in environmental monitoring, process control, and regulatory reporting solutions. | |
| Dismissing competitor concerns about market softness, signaling strong market position.When questioned about a competitor's recent warning on procedure softness and purchasing delays, the CEO stated STERIS has not seen any slowdown and feels good about its position. This suggests the company is outperforming peers, potentially gaining market share, and is a strong, stable partner for vendors. |
Signal API · MCP
Track Steris with the Signal API
One POST /v1/companies/enrich call with steris.com returns Steris 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"steris.com","signal_types":["sec-10q"],"limit":20}'Same industry
10-Q at related companies
Questions about Steris 10-Q
When did Steris file its latest 10-Q?
What did Steris disclose in its latest 10-Q?
What did Steris say on its recent earnings calls?
Where can I read Steris's 10-Q filing?
Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.
Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.
Data as of .